(2) | (47) | " (5) | # (2) | $ (1) | 0 (43) | 1 (528) | 2 (598) | 3 (345) | 4 (27) | 5 (21) | 6 (14) | 7 (7) | 8 (3) | 9 (4) | < (49) | A (336) | B (71) | C (270) | D (140) | E (194) | F (157) | G (461) | H (72) | I (178) | J (46) | K (72) | L (86) | M (209) | N (154) | O (62) | P (276) | Q (10) | R (113) | S (500) | T (561) | U (134) | V (38) | W (308) | X (9) | Y (15) | Z (8) |   (1) | Д (1) | П (1) | С (1) | إ (1) | ‘ (2) | “ (1)
Title Last update
Annex K. Form for Requests for Clarifications or Complaints after ITB awarding ITB-Iplus/GDF-MED/2023/5 Fri, 09/08/2023 - 04:17
Annex H. Indicative non-binding estimated quantities ITB-Iplus/GDF-MED/2023/5 Fri, 09/08/2023 - 04:14
Annex G. GDF access to supplier information for WHO PQP and ERP assessed TB medicines ITB-Iplus/GDF-MED/2023/5 Fri, 09/08/2023 - 04:12
Annex C. List of priority countries for TB medicines registration ITB-Iplus/GDF-MED/2023/5 Fri, 09/08/2023 - 04:08
Annex B - List and technical specifications of products requested ITB-Iplus/GDF-MED/2023/5 Fri, 09/08/2023 - 04:05
Annex A. Financial Bid Response Form ITB-Iplus/GDF-MED/2023/5 Fri, 09/08/2023 - 04:02
Archived procurement notices Fri, 09/08/2023 - 03:39
About 450,000 people estimated to have drug-resistant TB globally Wed, 09/06/2023 - 05:57
Access bedaquiline Wed, 08/30/2023 - 11:00
Annex K. Form for Requests for Clarifications or Complaints after ITB awarding ITB-Iplus/GDF-MED/2023/4 Mon, 08/28/2023 - 06:25
Annex H. Indicative non-binding estimated quantities ITB-Iplus/GDF-MED/2023/4 Mon, 08/28/2023 - 06:23
Annex G. GDF access to supplier information for WHO PQP and ERP assessed TB medicines ITB-Iplus/GDF-MED/2023/4 Mon, 08/28/2023 - 06:23
Annex C. List of priority countries for TB medicines registration ITB-Iplus/GDF-MED/2023/4 Mon, 08/28/2023 - 06:00
Annex B - List and technical specifications of products requested ITB-Iplus/GDF-MED/2023/4 Mon, 08/28/2023 - 05:59
Annex A. Financial Bid Response Form ITB-Iplus/GDF-MED/2023/4 Mon, 08/28/2023 - 05:56
Arusha Statement - Statement by Permanent Secretaries for health and NTP managers on accelerating ending TB in Africa Wed, 08/09/2023 - 12:19
About Wave 10 Call for Proposals Fri, 08/04/2023 - 10:32
Arusha Statement - Statement by Permanent Secretaries for health and national TB programme managers on accelerating ending TB in Africa Wed, 07/26/2023 - 07:34
Annex L. Declaration of supply restrictions for bedaquiline 100mg tablets Thu, 07/20/2023 - 09:03
Annex K. Form for Requests for Clarifications or Complaints after ITB awarding ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 09:01
Annex J. GDF packaging artwork development guidelines ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 08:59
Annex I. GMSD address list ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 08:58
Annex H. Indicative non-binding estimated quantities ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 08:57
Annex G. GDF access to supplier information for WHO PQP and ERP assessed TB medicines ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 08:56
Annex F. CDP technical tender submission - instructions for use ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 08:56
Annex E. i+solutions Code of Conduct for suppliers ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 08:55
Annex D. i+solutions model Long-Term Agreement (LTA) ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 08:53
Annex C. List of priority countries for TB medicines registration ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 08:52
Annex B. List and technical specifications of products requested ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 08:51
Annex A - Financial Bid Response Form ITB-Iplus/GDF-MED/2023/3 Thu, 07/20/2023 - 08:48
Annex K - Form for Requests for Clarifications or Complaints ITB-Iplus/GDF-MED/2023/2 Fri, 06/23/2023 - 04:19
Annex J - Global Drug Facility artwork development guidelines ITB-Iplus/GDF-MED/2023/2 Fri, 06/23/2023 - 04:13
Annex I - GMSDs address list ITB-Iplus/GDF-MED/2023/2 Fri, 06/23/2023 - 04:12
Annex H - Indicative non-binding estimated quantities of products requested ITB-Iplus/GDF-MED/2023/2 Fri, 06/23/2023 - 04:11
Annex G - GDF access to supplier information for WHO PQP and ERP assessed TB medicines ITB-Iplus/GDF-MED/2023/2 Fri, 06/23/2023 - 04:10
Annex F - CDP Technical Tender Submission - Instructions for use ITB-Iplus/GDF-MED/2023/2 Fri, 06/23/2023 - 04:09